Dilip Shanghvi's Sun pharma sets sights on InSite Vision of US; deal may be valued at about Rs 300 croreSun Pharmaceutical Industries has bid to acquire US eye care company InSite Vision to expand its basket of specialty products and boost sal...
Sun Pharma gains 2 per cent as company bids to acquire InSite VisionShares of Sun Pharmacauticals gained about 3% on reports that the company has bid to acquire US-based eye care company InSite Vision Inc.
Sun Pharma in race to acquire InSite Vision?InSite has notified QLT of the InSite Board of Directors' determination and will engage in discussions with the Bidder, it added.
Sun Pharma bids to acquire InSite Vision IncSources close to the transaction have indicated that Sun Pharma has already bid for US OTC Market listed Insite Vision for Rs 300 cr.
- Foodgrain mart evolves; MSP is virtually the floor price now
Stung by lessons of shortages and unremunerative prices for farmers in a “market-dominated” system, the foodgrain sector is showing early s...
- Food items won't be losing rupee appetite
Your home spend bill on daily essentials is unlikely to get significantly slimmer by April-May, after the RMS.
- Ranbaxy unveils two new drugs
Ranbaxy Labs on Monday announced the launch of two Novel Drug Delivery System (NDDS) products in the Urology Segment. Niftran 100mg Capsule...